Related Experiment Video
Updated: Jul 4, 2026

Robot Assisted Distal Pancreatectomy with Celiac Axis Resection (DP-CAR) for Pancreatic Cancer: Surgical Planning and Technique
Published on: August 14, 2021
Coagulation, anticoagulation and pancreatic carcinoma
Inaam A Nakchbandi1, J-Matthias Löhr
1Max-Planck Institute for Biochemistry, Martinsried, Germany and the University of Heidelberg, Heidelberg, Germany.
Patients with pancreatic cancer often experience increased coagulation. This review explores the link between coagulation, thromboembolic disease, and pancreatic cancer, examining anticoagulant treatments.
Area of Science:
- Oncology
- Hematology
- Pathophysiology
Background:
- Increased coagulation is a known complication in pancreatic cancer patients.
- The link between coagulation activation and pancreatic cancer development is under investigation.
- Thromboembolic disease is frequently observed in pancreatic cancer patients.
Purpose of the Study:
- To review the pathophysiology of increased coagulation in pancreatic cancer.
- To explore the relationship between coagulation, thromboembolic disease, and pancreatic cancer.
- To present evidence for anticoagulant use in pancreatic cancer patients.
Main Methods:
- Literature review of existing studies on coagulation and pancreatic cancer.
- Analysis of data linking thromboembolic disease with pancreatic cancer behavior.
- Critical appraisal of evidence for anticoagulation in pancreatic cancer.
Main Results:
- Pancreatic cancer is strongly associated with hypercoagulability.
- Thromboembolic events impact pancreatic cancer progression and outcomes.
- Evidence supports the use of anticoagulants in specific pancreatic cancer scenarios.
Conclusions:
- Understanding coagulation's role is crucial for managing pancreatic cancer.
- Anticoagulant therapy may offer benefits in pancreatic cancer patients.
- Further research is needed to optimize anticoagulation strategies.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis II: Pathophysiology
Venous Thrombosis III: Interprofessional Care
Chronic Pancreatitis II: Pathophysiology